Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A. Olsen, Eric C. Vonderheid, H. Miles Prince et al.|Journal of Clinical Oncology|2011Cited by 657
Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell LymphomaMadeleine Duvic, Larisa J. Geskin, Elise A. Olsen et al.|Clinical Lymphoma & Myeloma|2009Cited by 97